NPS and Other Emerging Drugs in the Clearnet and Darkweb.

I. Mazzoni
{"title":"NPS and Other Emerging Drugs in the Clearnet and Darkweb.","authors":"I. Mazzoni","doi":"10.1016/j.etdah.2023.100105","DOIUrl":null,"url":null,"abstract":"<div><div>Psychoactive substances have a long history of use as doping substances in sport, usually constituting the second most used drug class behind anabolic steroids. In addition to the classic doping substances, a more challenging problem is presented by the increasing availability of new psychoactive substances (NPS) and other emerging drugs (ED). These news drugs need first to be found and identified, classified based on the little information available as doping substances and finally analytical methods have to be developed or implemented in WADA accredited laboratories to detect them. In an effort to anticipate doping trends, one of the methods WADA uses is an intelligence-based approach, where new or potential doping substances are identified and purchased to confirm or identify their chemical structures and to assess their quality and purity. In this study we set out to monitor both the Darkweb and the Clearweb for emerging drugs with potential doping benefits. A comparison between the prevalence of these substances from both sources will be presented as well, to establish whether athletes have access to more sophisticated substances in the Darkweb. The presence of these NPS/ED as components of multipart nutritional subjects will be reported as well. These results will serve to target efforts to discover new substances entering the sport world for doping purposes and develop prevention and rapid-response strategies.</div></div>","PeriodicalId":72899,"journal":{"name":"Emerging trends in drugs, addictions, and health","volume":"4 ","pages":"Article 100105"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging trends in drugs, addictions, and health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667118223000569","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Psychoactive substances have a long history of use as doping substances in sport, usually constituting the second most used drug class behind anabolic steroids. In addition to the classic doping substances, a more challenging problem is presented by the increasing availability of new psychoactive substances (NPS) and other emerging drugs (ED). These news drugs need first to be found and identified, classified based on the little information available as doping substances and finally analytical methods have to be developed or implemented in WADA accredited laboratories to detect them. In an effort to anticipate doping trends, one of the methods WADA uses is an intelligence-based approach, where new or potential doping substances are identified and purchased to confirm or identify their chemical structures and to assess their quality and purity. In this study we set out to monitor both the Darkweb and the Clearweb for emerging drugs with potential doping benefits. A comparison between the prevalence of these substances from both sources will be presented as well, to establish whether athletes have access to more sophisticated substances in the Darkweb. The presence of these NPS/ED as components of multipart nutritional subjects will be reported as well. These results will serve to target efforts to discover new substances entering the sport world for doping purposes and develop prevention and rapid-response strategies.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Emerging trends in drugs, addictions, and health
Emerging trends in drugs, addictions, and health Pharmacology, Psychiatry and Mental Health, Forensic Medicine, Drug Discovery, Pharmacology, Toxicology and Pharmaceutics (General)
CiteScore
2.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信